Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and ...
The Washington Post on MSN2d
FTC sues pharmacy insurance managers, alleging unfair drug pricesThe Federal Trade Commission sued the three dominant pharmacy-benefit managers in the United States, alleging they inflated the cost of insulin by using their position as middlemen in the U.S.
The FTC report said the companies responsible for controlling spending on drugs were sometimes steering patients toward more ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback